HLA and MICA: Targets of antibody-mediated rejection in heart transplantation

Transplantation

Volumn 91, Issue 10, 2011, Pages 1153-1158

  Zhang, Qiuheng ^a   Cecka, J Michael ^a   Gjertson, David W ^a   Ge, Ping ^a   Rose, Marlene L ^b   Patel, Jignesh K ^a   Ardehali, Abbas ^a   Kobashigawa, Jon A ^a   Fishbein, Michael C ^a   Reed, Elaine F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Antibody medicated rejection; Chronic rejection; Endothelial cell antibody; HLA antibody; MICA; Non HLA antibody

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; IMMUNOGLOBULIN G;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY DETECTION; ANTIBODY MEDIATED REJECTION; ANTIGEN DETECTION; ARTICLE; CARDIAC GRAFT REJECTION; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEART TRANSPLANTATION; HLA TYPING; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATHOGENESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION;

ADULT; AGED; BIOPSY; CASE-CONTROL STUDIES; CELLS, CULTURED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEROLOGIC TESTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955634079     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182157d60     Document Type: Article

References (28)

1. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003; 3: 665.
2. Uber WE, Self SE, Van Bakel AB, et al. Acute antibody-mediated rejection following heart transplantation. Am J Transplant 2007; 7: 2064.
3. Michaels PJ, Espejo ML, Kobashigawa J, et al. Humoral rejection in cardiac transplantation: Risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 2003; 22: 58.
4. Mizutani K, Terasaki P, Rosen A, et al. Serial ten-year follow-up ofHLA and MICA antibody production prior to kidney graft failure. Am J Transplant 2005; 5: 2265.
5. Panigrahi A, Gupta N, Siddiqui JA, et al. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss. Hum Immunol 2007; 68: 362.
6. Suarez-Alvarez B, Lopez-Vazquez A, Gonzalez MZ, et al. The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection. Am J Transplant 2007; 7: 1842.
7. Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial ofHLAand MICA antibodies on kidney graft survival. Am J Transplant 2007; 7: 408.
8. Zwirner NW, Marcos CY, Mirbaha F, et al. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol 2000; 61: 917.
9. Zou Y, Stastny P, Susal C, et al. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 2007; 357: 1293.
10. Zou Y, Mirbaha F, Lazaro A, et al. MICA is a target for complementdependent cytotoxicity with mouse monoclonal antibodies and human alloantibodies. Hum Immunol 2002; 63: 30.
11. Le Bas-Bernardet S, Hourmant M, Coupel S, et al. Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis. Am J Transplant 2003; 3: 167.
12. Dunn MJ, Crisp SJ, Rose ML, et al. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 1992; 339: 1566.
13. Derhaag JG, Duijvestijn AM, Damoiseaux JG, et al. Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection. Transplantation 2000; 69: 1899.
14. Deal JE, Rigden SP, Harmer AW, et al. Renal allograft failure and antibodies to epithelial cells. Lancet 1992; 339: 941.
15. Claas FH, Paul LC, van Es LA, et al. Antibodies against donor antigens on endothelial cells and monocytes in eluates of rejected kidney allografts. Tissue Antigens 1980; 15: 19.
16. Dragun D, Muller DN, Brasen JH, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.NEngl J Med 2005; 352: 558.
17. Smith JD, Brunner VM, Jigjidsuren S, et al. Lack of effect of MICA antibodies on graft survival following heart transplantation. Am J Transplant 2009; 9: 1912.
18. Jurcevic S, Ainsworth ME, Pomerance A, et al. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 2001; 71: 886.
19. Dechend R, Homuth V, Wallukat G, et al. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 2000; 101: 2382.
20. Wulfkuhle JD, Speer R, Pierobon M, et al. Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. J Proteome Res 2008; 7: 1508.
21. Li L, Wadia P, Chen R, et al. Identifying compartment-specific non- HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci USA 2009; 106: 4148.
22. Zhang X, Reed EF. Effect of antibodies on endothelium. Am J Transplant 2009; 9: 2459.
23. Jin YP, Korin Y, Zhang X, et al. RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells. J Immunol 2007; 178: 7911.
24. Jin YP, Jindra PT, Gong KW, et al. Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection. Transplantation 2005; 79(3 suppl): S19.
25. Breimer ME, Rydberg L, Jackson AM, et al. Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplantation 2009; 87: 549.
26. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710.
27. Yeh M, Leitinger N, de Martin R, et al. Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF-alpha and oxidized phospholipids. Arterioscler Thromb Vasc Biol 2001; 21: 1585.
28. Mahesh B, Leong HS, McCormack A, et al. Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. Am J Pathol 2007; 170: 1415.